Cargando…

A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas

SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lei, Mugaanyi, Joseph, Zhang, Tongyue, Tong, Jingshu, Cai, Xingchen, Lu, Caide, Lu, Changjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/
https://www.ncbi.nlm.nih.gov/pubmed/36126083
http://dx.doi.org/10.1371/journal.pone.0274823
_version_ 1784792734084628480
author Dai, Lei
Mugaanyi, Joseph
Zhang, Tongyue
Tong, Jingshu
Cai, Xingchen
Lu, Caide
Lu, Changjiang
author_facet Dai, Lei
Mugaanyi, Joseph
Zhang, Tongyue
Tong, Jingshu
Cai, Xingchen
Lu, Caide
Lu, Changjiang
author_sort Dai, Lei
collection PubMed
description SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas.
format Online
Article
Text
id pubmed-9488775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94887752022-09-21 A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas Dai, Lei Mugaanyi, Joseph Zhang, Tongyue Tong, Jingshu Cai, Xingchen Lu, Caide Lu, Changjiang PLoS One Research Article SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas. Public Library of Science 2022-09-20 /pmc/articles/PMC9488775/ /pubmed/36126083 http://dx.doi.org/10.1371/journal.pone.0274823 Text en © 2022 Dai et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dai, Lei
Mugaanyi, Joseph
Zhang, Tongyue
Tong, Jingshu
Cai, Xingchen
Lu, Caide
Lu, Changjiang
A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_full A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_fullStr A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_full_unstemmed A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_short A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_sort pan-cancer bioinformatic analysis of the carcinogenic role of smarca1 in human carcinomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/
https://www.ncbi.nlm.nih.gov/pubmed/36126083
http://dx.doi.org/10.1371/journal.pone.0274823
work_keys_str_mv AT dailei apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT mugaanyijoseph apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT zhangtongyue apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT tongjingshu apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT caixingchen apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT lucaide apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT luchangjiang apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT dailei pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT mugaanyijoseph pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT zhangtongyue pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT tongjingshu pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT caixingchen pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT lucaide pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT luchangjiang pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas